Sutton Wealth Advisors Inc. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,171 filers reported holding NOVARTIS A G in Q4 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.

Quarter-by-quarter ownership
Sutton Wealth Advisors Inc. ownership history of NOVARTIS A G
ValueSharesWeighting
Q1 2023$4,876
-97.2%
53
-97.3%
0.00%
-95.5%
Q4 2022$175,543
+19.4%
1,9350.0%0.07%
+11.7%
Q3 2022$147,079
+82.8%
1,935
+103.3%
0.06%
+87.5%
Q2 2022$80,473
+81.2%
952
+88.1%
0.03%
+113.3%
Q1 2022$44,402
+857.8%
506
+854.7%
0.02%
+650.0%
Q4 2021$4,636
+7.0%
530.0%0.00%0.0%
Q3 2021$4,334
-10.4%
530.0%0.00%0.0%
Q2 2021$4,836
+6.8%
530.0%0.00%0.0%
Q1 2021$4,530
-9.5%
530.0%0.00%0.0%
Q4 2020$5,005
+8.6%
530.0%0.00%0.0%
Q3 2020$4,609
-0.4%
530.0%0.00%0.0%
Q2 2020$4,629
+5.9%
530.0%0.00%
-33.3%
Q1 2020$4,370
-12.9%
530.0%0.00%0.0%
Q4 2019$5,019
+9.0%
530.0%0.00%0.0%
Q3 2019$4,606
-4.8%
530.0%0.00%0.0%
Q2 2019$4,839
-5.0%
530.0%0.00%0.0%
Q1 2019$5,095
+12.0%
530.0%0.00%0.0%
Q4 2018$4,548
-0.4%
530.0%0.00%0.0%
Q3 2018$4,566
+14.0%
530.0%0.00%0.0%
Q2 2018$4,004
-6.6%
530.0%0.00%0.0%
Q1 2018$4,285
-3.7%
530.0%0.00%0.0%
Q4 2017$4,450
-2.2%
530.0%0.00%0.0%
Q3 2017$4,550
+2.8%
530.0%0.00%
-25.0%
Q2 2017$4,424
+12.4%
530.0%0.00%
+33.3%
Q1 2017$3,936
+1.9%
530.0%0.00%0.0%
Q4 2016$3,861
-7.7%
530.0%0.00%
-25.0%
Q3 2016$4,185
-4.3%
530.0%0.00%0.0%
Q2 2016$4,373
-85.0%
53
-86.8%
0.00%
-85.7%
Q1 2016$29,1934030.03%
Other shareholders
NOVARTIS A G shareholders Q4 2022
NameSharesValueWeighting ↓
PRENTISS SMITH & CO INC 127,510$11,721,0006.50%
MANAGED ASSET PORTFOLIOS, LLC 127,716$11,740,0006.04%
EXENCIAL WEALTH ADVISORS, LLC 116,917$10,747,0005.25%
MCDANIEL TERRY & CO 181,095$16,646,0004.64%
Fayerweather Charles 18,180$1,671,0004.54%
Osher Van de Voorde Investment Management 78,138$7,182,0004.38%
BROWN BROTHERS HARRIMAN & CO 9,291,495$854,074,0004.35%
Boulegeris Investments, Inc. 61,322$5,637,0004.31%
DODGE & COX 45,723,035$4,202,861,0004.23%
WHV Investments, Inc. 1,603,476$152,945,0004.23%
View complete list of NOVARTIS A G shareholders